$555 Million is the total value of Soleus Capital Management, L.P.'s 72 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 72.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCAB | BIOATLA INC | $161,639,000 | +49.5% | 3,179,362 | 0.0% | 29.12% | +104.1% | |
| EPIX | Sell | ESSA PHARMA INC | $60,135,000 | +112.2% | 2,070,052 | -12.9% | 10.84% | +189.7% |
| THTX | New | THERATECHNOLOGIES INC | $26,867,000 | – | 6,951,347 | +100.0% | 4.84% | – |
| ISEE | Buy | IVERIC BIO INC | $20,894,000 | +89.3% | 3,380,979 | +111.7% | 3.76% | +158.6% |
| LNTH | Buy | LANTHEUS HLDGS INC | $20,673,000 | +106.5% | 967,372 | +30.4% | 3.72% | +182.0% |
| CCCC | Buy | C4 THERAPEUTICS INC | $17,166,000 | +92.9% | 464,068 | +72.8% | 3.09% | +163.5% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $12,854,000 | +1956.6% | 166,844 | +1500.7% | 2.32% | +2724.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $12,850,000 | +299.8% | 258,446 | +302.0% | 2.32% | +446.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $12,675,000 | +47.7% | 708,117 | +26.9% | 2.28% | +101.6% |
| IRMD | Buy | IRADIMED CORP | $12,423,000 | +79.2% | 482,070 | +58.6% | 2.24% | +144.6% |
| VSPR | Buy | VESPER HEALTHCARE ACQSTN COR | $9,944,000 | +111.1% | 920,716 | +121.0% | 1.79% | +188.1% |
| GLTO | GALECTO INC | $9,189,000 | -51.4% | 1,512,648 | 0.0% | 1.66% | -33.7% | |
| SRDX | Buy | SURMODICS INC | $8,650,000 | +113.8% | 154,275 | +65.9% | 1.56% | +191.9% |
| INBX | Buy | INHIBRX INC | $8,058,000 | +14.3% | 401,493 | +87.8% | 1.45% | +56.1% |
| NTRA | Buy | NATERA INC | $7,944,000 | +7.6% | 78,239 | +5.5% | 1.43% | +46.9% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $6,468,000 | +131.7% | 270,080 | +92.2% | 1.16% | +216.6% |
| MSON | MISONIX INC | $5,903,000 | +56.7% | 301,333 | 0.0% | 1.06% | +114.1% | |
| PCVX | New | VAXCYTE INC | $5,800,000 | – | 293,650 | +100.0% | 1.04% | – |
| LYRA | Buy | LYRA THERAPEUTICS INC | $5,515,000 | +6.1% | 475,814 | +4.3% | 0.99% | +44.9% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $5,161,000 | – | 1,122,000 | +100.0% | 0.93% | – |
| MDXG | New | MIMEDX GROUP INC | $5,150,000 | – | 500,000 | +100.0% | 0.93% | – |
| FLXN | New | FLEXION THERAPEUTICS INC | $4,676,000 | – | 522,500 | +100.0% | 0.84% | – |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $4,243,000 | -15.1% | 97,256 | -9.8% | 0.76% | +16.1% |
| EXEL | Sell | EXELIXIS INC | $4,119,000 | -47.5% | 182,347 | -53.3% | 0.74% | -28.3% |
| RPTX | New | REPARE THERAPEUTICS INC | $4,092,000 | – | 133,324 | +100.0% | 0.74% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $3,871,000 | +30.8% | 25,318 | +33.7% | 0.70% | +78.7% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $3,824,000 | +51.8% | 61,151 | -8.6% | 0.69% | +107.5% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $3,735,000 | – | 86,100 | +100.0% | 0.67% | – |
| CUTR | New | CUTERA INC | $3,606,000 | – | 120,000 | +100.0% | 0.65% | – |
| PHG | New | KONINKLIJKE PHILIPS N Vny reg sh new | $3,482,000 | – | 61,050 | +100.0% | 0.63% | – |
| Sell | DARIOHEALTH CORP | $3,444,000 | -40.0% | 178,814 | -55.5% | 0.62% | -18.0% | |
| RFL | Sell | RAFAEL HLDGS INC | $3,419,000 | +40.0% | 85,637 | -18.2% | 0.62% | +91.3% |
| KNTE | New | KINNATE BIOPHARMA INC | $3,396,000 | – | 109,000 | +100.0% | 0.61% | – |
| NVCR | Buy | NOVOCURE LTD | $3,347,000 | -22.6% | 25,325 | +1.3% | 0.60% | +5.6% |
| Buy | GOSSAMER BIO INCnote 5.000% 6/0 | $3,328,000 | +34.4% | 3,750,000 | +36.4% | 0.60% | +83.5% | |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $3,318,000 | +541.8% | 313,064 | +662.4% | 0.60% | +779.4% |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $3,250,000 | – | 100,000 | +100.0% | 0.59% | – |
| New | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $3,216,000 | – | 1,950,000 | +100.0% | 0.58% | – | |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $3,142,000 | – | 300,000 | +100.0% | 0.57% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $3,138,000 | -49.2% | 142,137 | -28.9% | 0.56% | -30.8% |
| SIEN | New | SIENTRA INC | $2,755,000 | – | 377,900 | +100.0% | 0.50% | – |
| DYN | New | DYNE THERAPEUTICS INC | $2,708,000 | – | 174,360 | +100.0% | 0.49% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $2,624,000 | – | 57,200 | +100.0% | 0.47% | – |
| DXCM | Sell | DEXCOM INC | $2,492,000 | -17.4% | 6,935 | -15.1% | 0.45% | +12.8% |
| RNA | New | AVIDITY BIOSCIENCES INC | $2,380,000 | – | 109,130 | +100.0% | 0.43% | – |
| MRK | Buy | MERCK & CO. INC | $2,321,000 | -0.1% | 30,106 | +6.0% | 0.42% | +36.2% |
| NARI | New | INARI MED INC | $2,295,000 | – | 21,450 | +100.0% | 0.41% | – |
| New | CATABASIS PHARMACEUTICALS IN | $2,240,000 | – | 775,000 | +100.0% | 0.40% | – | |
| NEO | NEOGENOMICS INC | $2,216,000 | -10.4% | 45,951 | 0.0% | 0.40% | +22.4% | |
| EDAP | New | EDAP TMS S Asponsored adr | $2,096,000 | – | 249,566 | +100.0% | 0.38% | – |
| RNLX | New | RENALYTIX AI PLCads | $2,053,000 | – | 80,000 | +100.0% | 0.37% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $1,890,000 | -17.2% | 213,519 | +15.0% | 0.34% | +13.3% |
| STAA | Buy | STAAR SURGICAL CO | $1,760,000 | +574.3% | 16,700 | +406.1% | 0.32% | +832.4% |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $1,574,000 | -22.7% | 42,743 | 0.0% | 0.28% | +5.6% | |
| OCX | New | ONCOCYTE CORP | $1,541,000 | – | 297,000 | +100.0% | 0.28% | – |
| OSH | OAK STR HEALTH INC | $1,499,000 | -11.2% | 27,612 | 0.0% | 0.27% | +21.1% | |
| DFHT | New | DEERFIELD HEALTHCARE TECH AC | $1,441,000 | – | 118,900 | +100.0% | 0.26% | – |
| MORF | New | MORPHIC HLDG INC | $1,361,000 | – | 21,500 | +100.0% | 0.24% | – |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $1,322,000 | +11.3% | 26,101 | +6.6% | 0.24% | +51.6% |
| KDMN | KADMON HLDGS INC | $1,309,000 | -6.2% | 336,442 | 0.0% | 0.24% | +28.3% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,285,000 | +2.8% | 500,000 | 0.0% | 0.23% | +40.6% | |
| MGTA | New | MAGENTA THERAPEUTICS INC | $1,184,000 | – | 100,000 | +100.0% | 0.21% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $1,131,000 | – | 67,685 | +100.0% | 0.20% | – |
| TRILLIUM THERAPEUTICS INC | $1,115,000 | -27.0% | 103,819 | 0.0% | 0.20% | 0.0% | ||
| KYMR | Buy | KYMERA THERAPEUTICS INC | $1,093,000 | +34.4% | 28,116 | +114.4% | 0.20% | +84.1% |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $986,000 | -33.1% | 99,992 | -26.5% | 0.18% | -8.2% |
| ONCR | Buy | ONCORUS INC | $929,000 | -49.1% | 66,722 | +18.3% | 0.17% | -30.7% |
| RVNC | REVANCE THERAPEUTICS INC | $870,000 | -1.4% | 31,136 | 0.0% | 0.16% | +35.3% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $594,000 | -65.5% | 3,466 | -55.8% | 0.11% | -52.9% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $528,000 | -77.2% | 5,577 | -70.7% | 0.10% | -69.0% |
| HIMSWS | New | HIMS & HERS HEALTH INC*w exp 01/20/202 | $404,000 | – | 91,793 | +100.0% | 0.07% | – |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $395,000 | -61.4% | 42,684 | -25.0% | 0.07% | -47.4% |
| OACWS | Exit | OAKTREE ACQUISITION CORP*w exp 99/99/999 | $0 | – | -91,793 | -100.0% | -0.05% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -16,093 | -100.0% | -0.05% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -33,813 | -100.0% | -0.08% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -6,830 | -100.0% | -0.08% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -7,661 | -100.0% | -0.09% | – |
| MDNA | Exit | MEDICENNA THERAPEUTICS CORP | $0 | – | -186,799 | -100.0% | -0.12% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -12,655 | -100.0% | -0.12% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -3,899 | -100.0% | -0.13% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -22,631 | -100.0% | -0.14% | – |
| MGEN | Exit | MIRAGEN THERAPEUTICS INC | $0 | – | -81,185 | -100.0% | -0.18% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -9,589 | -100.0% | -0.22% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -10,825 | -100.0% | -0.22% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -105,941 | -100.0% | -0.24% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -21,477 | -100.0% | -0.30% | – |
| OAC | Exit | OAKTREE ACQUISITION CORP | $0 | – | -281,565 | -100.0% | -0.54% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -206,844 | -100.0% | -0.73% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -236,589 | -100.0% | -0.96% | – |
| Exit | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $0 | – | -8,500,000 | -100.0% | -1.14% | – | |
| NVTA | Exit | INVITAE CORP | $0 | – | -244,760 | -100.0% | -1.35% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -2,825,000 | -100.0% | -52.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.